Streetbeat News

Analyst Ratings

IOVA

HC Wainwright & Co. analyst Joseph Pantginis reiterates a Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA) and maintains a $38 price target.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 10:07 am

TPST

HC Wainwright & Co. analyst Joseph Pantginis reiterates a Buy rating on Tempest Therapeutics (NASDAQ:TPST) and maintains a $35 price target.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 10:07 am

BTAI

HC Wainwright & Co. analyst Raghuram Selvaraju reiterated a Buy rating on BioXcel Therapeutics (NASDAQ:BTAI) and maintained a $66 price target.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 10:06 am

VRTX

William Blair analyst Myles Minter initiates coverage on Vertex Pharmaceuticals (NASDAQ:VRTX) with an Outperform rating.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 10:00 am

SLRN

TD Cowen analyst Tyler Van Buren initiates coverage on Acelyrin (NASDAQ:SLRN) with an Outperform rating.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 9:59 am

LOW

Citigroup analyst Steven Zaccone maintains a Neutral rating on Lowe's Companies (NYSE:LOW) and raises the price target from $210 to $221.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 9:58 am

NVDA

BMO Capital analyst Ambrish Srivastava maintains an Outperform rating on NVIDIA and raises the price target from $350 to $450. The rating update was originally published on May 25, 2023.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 9:51 am

NTES

B of A Securities analyst Eddie Leung maintains a Buy rating on NetEase (NASDAQ:NTES) and raises the price target from $116 to $127.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 9:50 am

PAGS

Citigroup analyst Gabriel Gusan maintains a Buy rating on PagSeguro Digital (NYSE:PAGS) and raises the price target from $12 to $13.5.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 9:49 am

PDD

B of A Securities analyst Joyce Ju maintains a Buy rating on PDD Holdings (NASDAQ:PDD) and raises the price target from $95 to $97.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 9:47 am